The FDA has moved a major potato chip recall to its most serious classification, signaling heightened concern over potential salmonella contamination in products sold across the country. The agency designated the recall as Class 1, its top tier of alert, after manufacturer Utz initially issued a voluntary recall in May.
Roughly 650,000 bags of chips are caught in the recall, which affects multiple popular brands and varieties. The contaminated products carry best-by dates spanning from late July through the end of August. The source of the danger traces back to dry milk powder supplied by a third party that was used in seasoning ingredients.
Utz, headquartered in Hanover, Pennsylvania, first announced the recall out of caution despite reporting no confirmed salmonella presence in its products at that time. The company also said it had received no illness complaints related to the affected items. The decision to pull the chips from shelves came after the ingredient supplier itself issued a recall.
A Class 1 designation means there is reasonable probability that exposure to the product will cause serious health consequences or death, according to FDA standards. Despite this serious classification, the agency's official report provided no new detail about why the recall warranted the highest alert level or what specific risk prompted the upgrade.
The recalled products include multiple varieties under both the Zapp's and Dirty brand names. Flavors affected include Bayou Blackened Ranch, Salt and Vinegar, Big Cheezy, Maui Onion, and Sour Cream and Onion, available in package sizes ranging from 1.5 ounces to 8 ounces.
Salmonella bacteria cause food-borne illness and account for roughly one in four diarrheal diseases globally, per the World Health Organization. Infected individuals typically experience sudden fever, stomach pain, diarrhea, and nausea, with vomiting occurring in some cases.
Utz directed consumers not to eat any of the recalled products and advised discarding them immediately. The company also offered refunds to customers who had purchased affected items and urged them to contact Utz directly.
As of publication, Utz's website contained no updates beyond the original May announcement, and the FDA's enforcement report offered no further clarification on the timing or reasoning behind the Class 1 designation.
Author James Rodriguez: "The jump to Class 1 without public explanation leaves consumers in the dark about a threat the government considers potentially deadly, and that silence deserves scrutiny."
Comments